Terms: = Endocrine gland cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Diagnosis
22 results:
1. AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual src and MEK1/2 inhibition.
Rose MM; Nassar KW; Sharma V; Schweppe RE
Med Oncol; 2023 Sep; 40(10):299. PubMed ID: 37713162
[TBL] [Abstract] [Full Text] [Related]
2. Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS.
Chao A; Huang HJ; Lin CY; Lee CH; Lin CH; Chao AS; Lai CH; Chang TC; Wu KY; Wu RC
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37655726
[TBL] [Abstract] [Full Text] [Related]
3. A Rare Case of Synchronous Intraductal Papillary Mucinous Neoplasm-Associated Pancreatic Adenocarcinoma and Signet Ring Cell Gastric Adenocarcinoma.
Shupp B; Liaquat H; Rollins S; Stoll L; Singh G; Quiros RM; Matin A
Am J Case Rep; 2022 Aug; 23():e935242. PubMed ID: 35939415
[TBL] [Abstract] [Full Text] [Related]
4. Search for New Target Genes of MicroRNA for Differential diagnosis of Benign and Malignant Neoplasms of the Thyroid gland by In Silico Methods.
Kononchuk VV; Kopeikina EV; Kalinina TS; Saik OV; Alekseenok EY; Kolyagina MK; Matashova VA; Shevchenko SP; Gulyaeva LF; Kushlinskii NE
Bull Exp Biol Med; 2022 Jun; 173(2):246-251. PubMed ID: 35737153
[TBL] [Abstract] [Full Text] [Related]
5. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
[TBL] [Abstract] [Full Text] [Related]
6. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract] [Full Text] [Related]
7. RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.
Lian EY; Hyndman BD; Moodley S; Maritan SM; Mulligan LM
Oncogene; 2020 Oct; 39(41):6493-6510. PubMed ID: 32884116
[TBL] [Abstract] [Full Text] [Related]
8. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH
BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129
[TBL] [Abstract] [Full Text] [Related]
9. Silencing Delta-like 1 Expression Induces Migratory Features in Pancreatic cancer Cells Through Stimulation of src and p38 Signalling Pathway.
Lee J; Lee J; Kim DH; Kim JH
Anticancer Res; 2020 Mar; 40(3):1335-1344. PubMed ID: 32132030
[TBL] [Abstract] [Full Text] [Related]
10. Gene expression differences between thyroid carcinoma, thyroid adenoma and normal thyroid tissue.
Wang Q; Shen Y; Ye B; Hu H; Fan C; Wang T; Zheng Y; Lv J; Ma Y; Xiang M
Oncol Rep; 2018 Dec; 40(6):3359-3369. PubMed ID: 30272326
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
[TBL] [Abstract] [Full Text] [Related]
12. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/src/ERK axis in PDAC.
Cao XY; Zhang XX; Yang MW; Hu LP; Jiang SH; Tian GA; Zhu LL; Li Q; Sun YW; Zhang ZG
Biochem Biophys Res Commun; 2018 May; 499(3):584-593. PubMed ID: 29621546
[TBL] [Abstract] [Full Text] [Related]
13. Extracellular matrix protein ITGBL1 promotes ovarian cancer cell migration and adhesion through Wnt/PCP signaling and FAK/src pathway.
Sun L; Wang D; Li X; Zhang L; Zhang H; Zhang Y
Biomed Pharmacother; 2016 Jul; 81():145-151. PubMed ID: 27261588
[TBL] [Abstract] [Full Text] [Related]
14. CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma.
Nymoen DA; Holth A; Hetland Falkenthal TE; Tropé CG; Davidson B
Mol Cancer; 2015 Feb; 14():44. PubMed ID: 25889687
[TBL] [Abstract] [Full Text] [Related]
15. Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.
Gurbuz N; Ashour AA; Alpay SN; Ozpolat B
PLoS One; 2014; 9(8):e105245. PubMed ID: 25170871
[TBL] [Abstract] [Full Text] [Related]
16. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.
Zhi X; Tao J; Xie K; Zhu Y; Li Z; Tang J; Wang W; Xu H; Zhang J; Xu Z
Cancer Lett; 2014 Apr; 346(1):104-13. PubMed ID: 24374017
[TBL] [Abstract] [Full Text] [Related]
17. Quantitative proteomic profiling identifies DPYSL3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complex.
Kawahara T; Hotta N; Ozawa Y; Kato S; Kano K; Yokoyama Y; Nagino M; Takahashi T; Yanagisawa K
PLoS One; 2013; 8(12):e79654. PubMed ID: 24339867
[TBL] [Abstract] [Full Text] [Related]
18. Adrenocortical carcinoma: a comprehensive immunohistochemical study of 40 cases.
Weissferdt A; Phan A; Suster S; Moran CA
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):24-30. PubMed ID: 23531850
[TBL] [Abstract] [Full Text] [Related]
19. Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-src in detached pancreatic cells.
Connelly SF; Isley BA; Baker CH; Gallick GE; Summy JM
Mol Carcinog; 2010 Dec; 49(12):1007-21. PubMed ID: 20945416
[TBL] [Abstract] [Full Text] [Related]
20. The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia.
Zhu P; Ning Y; Yao L; Chen M; Xu C
J Exp Clin Cancer Res; 2010 Sep; 29(1):124. PubMed ID: 20831794
[TBL] [Abstract] [Full Text] [Related]
[Next]